A detailed history of Bessemer Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 41,625 shares of ATRC stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,625
Previous 35,636 16.81%
Holding current value
$1.5 Million
Previous $811,000 44.02%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$20.34 - $29.5 $121,816 - $176,675
5,989 Added 16.81%
41,625 $1.17 Million
Q2 2024

Aug 13, 2024

BUY
$19.86 - $29.09 $2,700 - $3,956
136 Added 0.38%
35,636 $811,000
Q1 2024

May 13, 2024

BUY
$28.21 - $37.78 $229,065 - $306,773
8,120 Added 29.66%
35,500 $1.08 Million
Q4 2023

Feb 09, 2024

BUY
$32.99 - $43.25 $306,147 - $401,360
9,280 Added 51.27%
27,380 $977,000
Q3 2023

Nov 13, 2023

BUY
$41.12 - $57.73 $335,045 - $470,384
8,148 Added 81.87%
18,100 $793,000
Q2 2023

Aug 10, 2023

BUY
$40.44 - $49.6 $402,458 - $493,619
9,952 New
9,952 $491,000
Q3 2022

Nov 09, 2022

BUY
$38.25 - $52.62 $2,371 - $3,262
62 New
62 $2,000
Q3 2020

Nov 12, 2020

SELL
$38.36 - $46.91 $1.43 Million - $1.75 Million
-37,200 Closed
0 $0
Q1 2020

Apr 30, 2020

SELL
$24.49 - $43.84 $389,391 - $697,056
-15,900 Reduced 29.94%
37,200 $1.25 Million
Q4 2019

Feb 04, 2020

SELL
$24.06 - $32.51 $1.04 Million - $1.41 Million
-43,300 Reduced 44.92%
53,100 $1.73 Million
Q3 2019

Nov 07, 2019

BUY
$23.81 - $32.52 $302,387 - $413,004
12,700 Added 15.17%
96,400 $2.4 Million
Q2 2019

Jul 19, 2019

BUY
$26.85 - $30.74 $373,215 - $427,286
13,900 Added 19.91%
83,700 $2.5 Million
Q1 2019

May 13, 2019

BUY
$26.38 - $33.34 $1.64 Million - $2.07 Million
62,200 Added 818.42%
69,800 $1.87 Million
Q4 2018

Feb 12, 2019

BUY
$26.66 - $34.85 $202,616 - $264,860
7,600 New
7,600 $233,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.67B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.